EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

A Decade of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer in Spain: A Comprehensive Real-World Data Analysis (2013-2023)

Vicente Peg, Octavio Burgués, Irune Ruiz, David Carcedo, José Francisco García, Mario A Monzón Naranjo, Ivana Tonic, Teresa Echeverría, Ana Segura, Natividad Alfonsín, María Concepción Fiaño, Belén Pérez-Mies

Clinical Breast Cancer · 2026-06 · 26 (6) · 104-112.e1

DOI: 10.1016/j.clbc.2026.04.009 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical Breast Cancer, 2026-06. Verfasst von Vicente Peg und 11 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Department, Hospital Vall d´Hebron, Barcelona, Spain. Electronic address: vicente.peg@vallhebron.cat. Hauptthemen laut MEDLINE: Erb-b2 Receptor Tyrosine Kinases, Breast Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Farma SA, Roche.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Erb-b2 Receptor Tyrosine KinasesBreast NeoplasmsBiomarkers, TumorHumansFemaleSpainRetrospective StudiesRegistriesImmunohistochemistryMiddle AgedIn Situ HybridizationAdultAged

Stichwörter der Autor:innen

ASCO-CAP guidelinesBreast cancerHER2

Substanzen

Erb-b2 Receptor Tyrosine KinasesERBB2 protein, humanBiomarkers, Tumor

Autor:innen und Institutionen

  • Pathology Department, Hospital Vall d´Hebron, Barcelona, Spain. Electronic address: vicente.peg@vallhebron.cat.
  • Pathology Department, Hospital Universitario de Valencia, Valencia, Spain.
  • Pathology Department, Hospital Universitario Donostia, San Sebastián, Spain.
  • Pathology Department, Hygeia Consulting SL, Madrid, Spain.
  • Roche Farma S.A, Madrid, Spain.
  • Roche Diagnostics, Sant Cugat del Vallès, Spain.

Förderung

  • Roche Farma SA
  • Roche

Zitieren

APA

Peg, V., Burgués, O., Ruiz, I., Carcedo, D., García, J. F., Monzón Naranjo, M. A., Tonic, I., Echeverría, T., Segura, A., Alfonsín, N., Fiaño, M. C., & Pérez-Mies, B. (2026). A Decade of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer in Spain: A Comprehensive Real-World Data Analysis (2013-2023). Clinical Breast Cancer, 26(6), 104-112.e1. https://doi.org/10.1016/j.clbc.2026.04.009

Vancouver

Peg V, Burgués O, Ruiz I, Carcedo D, García JF, Monzón Naranjo MA, et al. A Decade of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer in Spain: A Comprehensive Real-World Data Analysis (2013-2023). Clinical Breast Cancer. 2026;26(6):104-112.e1. doi:10.1016/j.clbc.2026.04.009

BibTeX
@article{Peg2026,
  author = {Peg, Vicente and Burgués, Octavio and Ruiz, Irune and Carcedo, David and García, José Francisco and Monzón Naranjo, Mario A and Tonic, Ivana and Echeverría, Teresa and Segura, Ana and Alfonsín, Natividad and Fiaño, María Concepción and Pérez-Mies, Belén},
  title = {A Decade of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Breast Cancer in Spain: A Comprehensive Real-World Data Analysis (2013-2023)},
  journal = {Clinical Breast Cancer},
  year = {2026},
  volume = {26},
  number = {6},
  pages = {104--112.e1},
  doi = {10.1016/j.clbc.2026.04.009}
}
Kostenlos starten →